Quantbot Technologies’s Adaptive Biotechnologies ADPT Stock Holding History

Quantbot Technologies’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$295K	Sell	13,744 -2,227	-14%	-$34.1K	0.01%	1120
2026 Q1	$222K	Buy	+15,971	New	+$254K	0.01%	1143
2025 Q3	–	Sell	-50,374	Closed	-$587K	–	1701
2025 Q2	$587K	Buy	+50,374	New	+$458K	0.02%	957
2024 Q2	–	Sell	-26,474	Closed	-$85K	–	1384
2024 Q1	$85K	Buy	+26,474	New	+$102K	﹤0.01%	1228
2022 Q4	–	Sell	-79,812	Closed	-$568K	–	1620
2022 Q3	$568K	Buy	+79,812	New	+$752K	0.04%	537
2022 Q2	–	Sell	-30,728	Closed	-$426K	–	1652
2022 Q1	$426K	Buy	+30,728	New	+$483K	0.04%	638
2021 Q2	–	Sell	-10,793	Closed	-$434K	–	1416
2021 Q1	$434K	Buy	+10,793	New	+$584K	0.04%	529
2019 Q4	–	Sell	-4,051	Closed	-$125K	–	1174
2019 Q3	$125K	Buy	+4,051	New	+$165K	0.01%	790

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quantbot Technologies's ADPT Position: Q2 2026 in Review

Quantbot Technologies reduced its Adaptive Biotechnologies (ADPT) stake by 14% in Q2 2026, selling an estimated $34.1K and leaving 13,744 shares worth $295K. The position accounts for 0.01% of the portfolio, ranked #1120.

Quantbot Technologies first reported a position in ADPT in Q3 2019 and has held it in 8 quarters since. The position peaked at $587K in Q2 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Quantbot Technologies held 13,744 shares of Adaptive Biotechnologies worth $295K as of Q2 2026.
Quantbot Technologies sold 2,227 Adaptive Biotechnologies shares in Q2 2026, an estimated $34.1K.
Adaptive Biotechnologies made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1120 holding.
Quantbot Technologies first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 8 quarters since.
Quantbot Technologies's Adaptive Biotechnologies position peaked at $587K in Q2 2025.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.